{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-143187","form_type":"8-K","ticker":"ANTX","cik":"0001880438","company_name":"AN2 Therapeutics, Inc.","filed_at":"2025-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.358102+00:00","generated_at":"2026-05-19T01:55:42.587581+00:00","sec_items":["3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"AN2 Therapeutics exchanges 2.8M common shares for pre-funded warrants with Coastlands Capital","bullets":["Exchanged 2,500,000 shares of common stock for pre-funded warrant for 2,500,000 shares on June 17, 2025.","Exchanged additional 300,000 shares for pre-funded warrant for 300,000 shares on June 19, 2025.","Warrants have $0.00001 exercise price, no expiration, and beneficial ownership blocker at 9.99% (up to 19.99%).","Issued under Section 3(a)(9) exemption from registration; form of warrant filed as Exhibit 4.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-143187","json":"https://secwatch.observer/filing/0001193125-25-143187.json","markdown":"https://secwatch.observer/filing/0001193125-25-143187.md","text":"https://secwatch.observer/filing/0001193125-25-143187.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1880438/000119312525143187/0001193125-25-143187-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1880438/000119312525143187/d50241d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T01:55:42.587581+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}